BACKGROUND: Percutaneous left atrial appendage closure (LAAC) is usually performed under general anesthesia (GA) guided by transesophageal echocardiography (TEE), or under local anesthesia (LA) guided by intracardiac echocardiography (ICE). GA is known to carry some disadvantages. It is sometimes technically challenging to obtain adequate imaging of the left atrial appendage (LAA) with LAAC guided by ICE. This study aimed to assess the safety and clinical efficacy of LAAC guided by TEE under LA in patients with non-valvular atrial fibrillation (AF). METHODS: A total of 159 patients (70.5 ± 8.2 years; 66% male) with AF who had a high risk of stroke and bleeding or who had contraindications for oral anticoagulation underwent LAAC under LA. TEE or computed tomography (CT) follow-up was scheduled approximately 6 weeks after the procedure. Patients were followed to assess ischemic stroke and major bleeding events. RESULTS: The LAA was successfully occluded in 152 patients (95.6%). There were 2 (1.3%) periprocedural major adverse events. A total of 142 patients (93.4%) finished TEE or CT follow-up. Thrombus formation as seen on the device was documented in 2 patients. All of the LAAs were completely sealed with the absence of flow or with minimal flow. The median follow-up period was 522 days, resulting in a total of 216 patient-years. Ischemic stroke occurred in 4 patients. The annual ischemic stroke rate was 1.9/100 person-years. Major bleeding occurred in 2 patients. The annual major bleeding rate was 1.9/100 person-years. CONCLUSIONS: In this study, percutaneous LAAC using TEE under LA was safe and showed encouraging results for stroke prevention and major bleeding reduction.
BACKGROUND: Percutaneous left atrial appendage closure (LAAC) is usually performed under general anesthesia (GA) guided by transesophageal echocardiography (TEE), or under local anesthesia (LA) guided by intracardiac echocardiography (ICE). GA is known to carry some disadvantages. It is sometimes technically challenging to obtain adequate imaging of the left atrial appendage (LAA) with LAAC guided by ICE. This study aimed to assess the safety and clinical efficacy of LAAC guided by TEE under LA in patients with non-valvular atrial fibrillation (AF). METHODS: A total of 159 patients (70.5 ± 8.2 years; 66% male) with AF who had a high risk of stroke and bleeding or who had contraindications for oral anticoagulation underwent LAAC under LA. TEE or computed tomography (CT) follow-up was scheduled approximately 6 weeks after the procedure. Patients were followed to assess ischemic stroke and major bleeding events. RESULTS: The LAA was successfully occluded in 152 patients (95.6%). There were 2 (1.3%) periprocedural major adverse events. A total of 142 patients (93.4%) finished TEE or CT follow-up. Thrombus formation as seen on the device was documented in 2 patients. All of the LAAs were completely sealed with the absence of flow or with minimal flow. The median follow-up period was 522 days, resulting in a total of 216 patient-years. Ischemic stroke occurred in 4 patients. The annual ischemic stroke rate was 1.9/100 person-years. Major bleeding occurred in 2 patients. The annual major bleeding rate was 1.9/100 person-years. CONCLUSIONS: In this study, percutaneous LAAC using TEE under LA was safe and showed encouraging results for stroke prevention and major bleeding reduction.
Entities:
Keywords:
Atrial fibrillation; Local anesthesia; Major bleeding; Percutaneous left atrial appendage closure; Stroke prevention
Authors: Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip Journal: Chest Date: 2010-03-18 Impact factor: 9.410
Authors: Alexander Sedaghat; Baravan Al-Kassou; Vivian Vij; Dominik Nelles; Marko Stuhr; Robert Schueler; Heyder Omran; Jan Wilko Schrickel; Christoph Hammerstingl; Georg Nickenig Journal: Clin Res Cardiol Date: 2018-12-10 Impact factor: 5.460
Authors: Chak-Yu So; Yat-Yin Lam; Gary Shing-Him Cheung; Christy K Y Chan; Shaojie Chen; Anna Kin-Yin Chan; Jai-Wun Park; Boris Schmidt; Bryan P Yan Journal: JACC Cardiovasc Interv Date: 2018-06-11 Impact factor: 11.195
Authors: E J Bakker; K M van de Luijtgaarden; F van Lier; T M Valentijn; S E Hoeks; M Klimek; H J M Verhagen; R J Stolker Journal: Eur J Vasc Endovasc Surg Date: 2012-05-22 Impact factor: 7.069
Authors: Fabian Nietlispach; Steffen Gloekler; René Krause; Samera Shakir; Michael Schmid; Ahmed A Khattab; Peter Wenaweser; Stephan Windecker; Bernhard Meier Journal: Catheter Cardiovasc Interv Date: 2013-03-22 Impact factor: 2.692
Authors: Ondrej Jor; Jan Maca; Jirina Koutna; Michaela Gemrotova; Tomas Vymazal; Martina Litschmannova; Pavel Sevcik; Petr Reimer; Vera Mikulova; Michaela Trlicova; Vladimir Cerny Journal: J Anesth Date: 2018-07-19 Impact factor: 2.078
Authors: Majd E Hemam; Kenji Kuroki; Paul A Schurmann; Amish S Dave; Diego A Rodríguez; Luis C Sáenz; Vivek Y Reddy; Miguel Valderrábano Journal: Heart Rhythm Date: 2019-03 Impact factor: 6.343